GGrantIndex
← Leaderboards

Martin Rhys Farlow

Indiana Univ-Purdue Univ At Indianapolis

$7,840,800
Attributed
$12,106,757
Total exposure
4
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.3M · FY200622
$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22

Funding mix

By agency

NIH$12,106,757 · 4

By mechanism

R01$6,398,936 · 1
P30$5,707,821 · 2
M01$0 · 1

Top collaborators

Most similar at Indiana Univ-Purdue Univ At Indianapolis

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos

Research focus

Alzheimer&AposPlasmaDementiaAfrican AmericanClinical ResearchCerebrospinal FluidSamplingDiagnosisS DiseaseMild Cognitive ImpairmentAlzheimer'S DiseaseBiomarkerHuman SubjectPatient CareFamily GeneticsPhenotypeNeuropharmacologyGenotypeNeuropsychologyBiomedical FacilityDiagnosis Design /EvaluationDisease /Disorder Proneness /RiskBiological MarkersBrain Disorder Diagnosis

Grant awards (27)

Multi-center development of a novel diagnostic test for Alzheimer's disease$1,266,625
R01 · FY2022 · AG
Multi-center development of a novel diagnostic test for Alzheimer's disease$1,275,411
R01 · FY2021 · AG
Multi-center development of a novel diagnostic test for Alzheimer's disease$1,275,411
R01 · FY2020 · AG
Multi-center development of a novel diagnostic test for Alzheimer's disease$1,275,411
R01 · FY2019 · AG
Multi-center development of a novel diagnostic test for Alzheimer's disease$1,306,078
R01 · FY2018 · AG
Clinical Core$608,245
P30 · FY2015 · AG · contact PI
Clinical Core$527,015
P30 · FY2014 · AG · contact PI
Clinical Core$497,749
P30 · FY2013 · AG · contact PI
CORE--CLINICAL$784,652
P30 · FY2010 · AG · contact PI
CORE--CLINICAL$772,980
P30 · FY2009 · AG · contact PI
CORE--CLINICAL$620,024
P30 · FY2008 · AG · contact PI
CORE--CLINICAL$615,587
P30 · FY2007 · AG · contact PI
CORE--CLINICAL$330,507
P30 · FY2006 · AG · contact PI
CORE-- CLINICAL$178,517
P30 · FY2002 · AG
CORE-- CLINICAL$178,517
P30 · FY2002 · AG
CORE-- CLINICAL$178,517
P30 · FY2002 · AG
CORE-- CLINICAL$178,517
P30 · FY2002 · AG
STUDY OF AIT 082 IN MILD ALZHEIMER'S DISEASE PATIENTS$0
M01 · FY2002 · RR
CORE-- CLINICAL$0
P30 · FY2001 · AG
CORE-- CLINICAL$0
P30 · FY2001 · AG
STUDY OF AIT 082 IN MILD ALZHEIMER'S DISEASE PATIENTS$0
M01 · FY2001 · RR
CORE-- CLINICAL$236,994
P30 · FY2000 · AG
STUDY OF AIT 082 IN MILD ALZHEIMER'S DISEASE PATIENTS$0
M01 · FY2000 · RR
STUDY OF AIT 082 IN MILD ALZHEIMER'S DISEASE PATIENTS$0
M01 · FY2000 · RR
STUDY OF AIT 082 IN MILD ALZHEIMER'S DISEASE PATIENTS$0
M01 · FY2000 · RR
STUDY OF AIT 082 IN MILD ALZHEIMER'S DISEASE PATIENTS$0
M01 · FY2000 · RR
STUDY OF AIT 082 IN MILD ALZHEIMER'S DISEASE PATIENTS$0
M01 · FY2000 · RR